Skip to main content
OpenTrials
Completed

NCT Number: NCT01354327

Effects of Limicol on LDL-cholesterol

The principal objective of this study is to investigate the effects of a novel food supplement (Limicol) on LDL-cholesterol levels in healthy subjects with moderate hypercholesterolemia.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • About 18 to 55 years (inclusive)
  • Subject has a stable weight for at least three months before the start of the study
  • Subject able and willing to comply with the protocol and agreeing to give their consent in writing
  • Subject affiliated with a social security scheme
  • Subject willing to be included in the national register of volunteers who lend themselves to biomedical research

Treatment and study plan

LIMICOL

Dietary Supplement

3 tablets / day during 4 months

Placebo

Dietary Supplement

3 tablets / day during 4 months

Primary outcomes

  1. Change from Baseline in blood LDL-cholesterol levels at 4 months

    Time frame: 4 months

Secondary outcomes

  1. Change from Baseline in blood Vit. C, Vit. E, polyphenols and MDA levels at 4 months

    Time frame: 4 months

Sponsors and collaborators

Lead sponsor

Lescuyer Laboratory

Industry

Collaborators

  • Aix Marseille Université
  • CIC Hôpital de la Conception - Marseille

Registry information

Official study title

Study of the Effects of Limicol (a Food Supplement) on LDL-cholesterol in Moderate Hypercholesterolemia Subjects

Important dates

Study start
2008
Primary completion
2011
Study completion
2011
First posted
May 16, 2011
Registry last updated
May 16, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.